MSD exercises its option on vaccine candidate EVX-B3 for a cash payment of $7.5 million, which extend Evaxion’s cash runway to first half of 2027 MSD will assume full responsibility for the further ...
COPENHAGEN - Evaxion Biotech A/S (NASDAQ: EVAX), a clinical-stage TechBio company, has entered into an option and license agreement with pharmaceutical giant MSD, known as Merck & Co., Inc. in the U.S ...
There was a time when the size of your car’s rear tire could severely inhibit dragstrip performances. The only “power management” available was your own foot and optimal traction was had by stuffing ...
The company will expand its production facilities in Carlow and Cork to meet increased global demand for its medicines and vaccines produced in Ireland. MSD, known as Merck in the US and Canada, ...
Hot rodding has always been and will always be a cannibalistic hobby. We steal from the rich new technology of current-year cars and adapt those parts to our poor and outdated hot rods. It's a ...
A new 20,000-L microbial biologics facility in Ireland will be operational by 2018 for Fujifilm Diosynth's contract development and manufacturing customers. CDMO Fujifilm Diosynth Biotechnologies is ...
What if we had an ergonomics standard? What if business understood the value of ergonomics? How would that impact workplace safety? Reflection is a very powerful tool. Stealing away some quiet time ...
BLUE BELL, Pa.--(BUSINESS WIRE)--BrightView Holdings, Inc. (NYSE: BV) today announced that it has entered into an agreement to repurchase 5.9 million shares of BrightView common stock from MSD ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback